N6W

benzo[b][1]benzazepine-11-carboxamide


Toggle HydrogenToggle Labels

Chemical Component Summary

Namebenzo[b][1]benzazepine-11-carboxamide
Identifiersbenzo[b][1]benzazepine-11-carboxamide
FormulaC15 H12 N2 O
Molecular Weight236.269
TypeNON-POLYMER
Isomeric SMILESc1ccc2c(c1)C=Cc3ccccc3N2C(=O)N
InChIInChI=1S/C15H12N2O/c16-15(18)17-13-7-3-1-5-11(13)9-10-12-6-2-4-8-14(12)17/h1-10H,(H2,16,18)
InChIKeyFFGPTBGBLSHEPO-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count30
Chiral Atom Count0
Bond Count32
Aromatic Bond Count12

Drug Info: DrugBank

DrugBank IDDB00564 
NameCarbamazepine
Groups
  • investigational
  • approved
DescriptionCarbamazepine, also known as Tegretol, is an anticonvulsant drug and analgesic drug used to control seizures and to treat pain resulting from trigeminal neuralgia. It was initially approved by the FDA in 1965.[A180301] Aside from the above uses, this drug is also given to control the symptoms of bipolar 1.[L1335] Interestingly, carbamazepine was the first anticonvulsant used to treat individuals with bipolar disorder.[A180319]
Synonyms
  • Molecusol-Carbamazepine
  • 5-Carbamyl-5H-dibenzo(b,f)azepine
  • 5H-Dibenz(b,f)azepine-5-carboxamide
  • Carbamazepin
  • Carbamazépine
Brand Names
  • Carbamazepine CR
  • Sandoz-carbamazepine CR
  • Carbamazepine 200 Tab 200mg
  • Equetro
  • Apo-carbamazepine CR
IndicationCarbamazepine is indicated for the treatment of epilepsy and pain associated with true trigeminal neuralgia.[L1335] In particular, carbamazepine has shown efficacy in treating mixed seizures, partial seizures with complex symptoms, and generalized tonic-clonic seizures.[A180301,L1335] Carbamazepine is also indicated for the treatment of manic episodes and mixed manic-depressive episodes caused by bipolar I disorder.[L1335] Some off-label, unapproved uses of carbamazepine include the treatment of alcohol withdrawal syndrome and restless leg syndrome.[A180415,A180421]
Categories
  • Analgesics
  • Analgesics, Non-Narcotic
  • Anticonvulsants
  • Antimanic Agents
  • Carboxamide Derivatives
ATC-CodeN03AF01
CAS number298-46-4

Drug Targets

NameTarget SequencePharmacological ActionActions
Voltage-gated sodium channel alpha subunitMEQTVLVPPGPDSFNFFTRESLAAIERRIAEEKAKNPKPDKKDDDENGPK...unknowninhibitor
Neuronal acetylcholine receptor subunit alpha-4MELGGPGAPRLLPPLLLLLGTGLLRASSHVETRAHAEERLLKKLFSGYNK...unknown
Nuclear receptor subfamily 1 group I member 2MEVRPKESWNHADFVHCEDTESVPGKPSVNADEEVGGPQICRVCGDKATG...unknownactivator
Cytochrome P450 3A4MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNI...unknownsubstrate,inducer
Cytochrome P450 2C8MEPFVVLVLCLSFMLLFSLWRQSCRRRKLPPGPTPLPIIGNMLQIDVKDI...unknownsubstrate,inducer
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
Pharos CHEMBL108
PubChem 2554
ChEMBL CHEMBL108
ChEBI CHEBI:3387
CCDC/CSD CBMZPN18, LOFKIB01, CBMZPN23, MOXVIF, LEZKEI01, CBMZPN17, CBMZPN01, CBMZPN12, MOXVOL, FAYYAI, FAYXUB, LEXQAJ, FAYXOV, CBMZPN10, CBMZPN20, LEZKEI, CBMZPN14, CBMZPN22, MOXVIF01, HORWIX, CBMZPN27, MOXVAX, MOXWAY, JIQLAZ, CBMZPN16, HUQWOH, LEXPOW, LEXPIQ, LOFKIB, BIXBOC, CBMZPN11, FEFNOT03, MOXVEB, KIWBOI, MOXWEC, MOXVIF03, KICWOK, JIQLED, FOMXAH, JIQKUS, CBMZPN21, FEFNOT04, CBMZPN03, FEFNOT02, CRBMZA01, ABOQUF, CBMZPN02, EYEJAW, CBMZPN33
COD 2205799, 2205821, 2205976, 4508997, 4509211, 4509213, 4509214, 4509215, 4509216, 4509217, 4509218, 4509219, 4509220, 4509221, 4509222, 2216052, 4100977, 4510731, 4510732, 4510733, 7106548, 1506790, 4500002, 4500003, 4500004, 4500005, 4500007, 4500008, 4500010, 4500011, 4500012, 4512302, 7203285, 4502452, 2019240, 7216032, 4503359, 7227180, 2107460, 7228537, 7228538, 7228539, 2300327, 2300417, 2311081, 2311083, 2311085, 1505213